ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea flag South Korea · Delayed Price · Currency is KRW
73,900
+300 (0.41%)
May 14, 2025, 2:40 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Raw Pharmaceutical Products
251.56B
Log In
Log In
Log In
Log In
Raw Pharmaceutical Products Growth
20.21%
Log In
Log In
Log In
Log In
Clinical Trial Contract Research
33.43B
Log In
Log In
Log In
Log In
Clinical Trial Contract Research Growth
-16.52%
Log In
Log In
Log In
Log In
New Drugs and Generic Drug Product
-
Log In
Log In
Log In
Log In
New Drugs and Generic Drug Product Growth
-
Log In
Log In
Log In
Log In
New Drugs and Generic Drug Merchandise
-
Log In
Log In
Log In
Log In
New Drugs and Generic Drug Merchandise Growth
-
Log In
Log In
Log In
Log In
Service
-
Log In
Log In
Log In
Log In
Service Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Switzerland
98.64B
Log In
Log In
Log In
Log In
Switzerland Growth
-10.53%
Log In
Log In
Log In
Log In
Other Countries
66.28B
Log In
Log In
Log In
Log In
Other Countries Growth
17.94%
Log In
Log In
Log In
Log In
South Korea
51.95B
Log In
Log In
Log In
Log In
South Korea Growth
-1.17%
Log In
Log In
Log In
Log In
United States
39.84B
Log In
Log In
Log In
Log In
United States Growth
31.45%
Log In
Log In
Log In
Log In
Belgium
28.28B
Log In
Log In
Log In
Log In
Spain
-
Log In
Log In
Log In
Log In